Publicaciones en las que colabora con FERNANDO HUETE TORAL (12)

2022

  1. Contact Lenses Loaded with Melatonin Analogs: A Promising Therapeutic Tool against Dry Eye Disease

    Journal of Clinical Medicine, Vol. 11, Núm. 12

  2. Dual-Mode Gold Nanoparticle-Based Method for Early Detection of Acanthamoeba

    International Journal of Molecular Sciences, Vol. 23, Núm. 23

2020

  1. Optimization of a Rabbit Dry Eye Model Induced by Topical Instillation of Benzalkonium Chloride

    Journal of Ophthalmology, Vol. 2020

2019

  1. Effect of Melatonin and Its Analogs on Tear Secretion

    The Journal of pharmacology and experimental therapeutics, Vol. 371, Núm. 1, pp. 186-190

2017

  1. Low expression of CD39 and CD73 genes in centenarians compared with octogenarians

    Immunity and Ageing, Vol. 14, Núm. 1

  2. The role and therapeutic potential of melatonin in age-related ocular diseases

    Journal of Pineal Research, Vol. 63, Núm. 2

2015

  1. Melatonin receptors trigger cAMP production and inhibit chloride movements in nonpigmented ciliary epithelial cells

    Journal of Pharmacology and Experimental Therapeutics, Vol. 352, Núm. 1, pp. 119-128

2014

  1. An update on dry eye disease molecular treatment: Advances in drug pipelines

    Expert Opinion on Pharmacotherapy, Vol. 15, Núm. 10, pp. 1371-1390

2013

  1. Melatonin and its analog 5-methoxycarbonylamino-N-acetyltryptamine potentiate adrenergic receptor-mediated ocular hypotensive effects in rabbits: Significance for combination therapy in glaucoma

    Journal of Pharmacology and Experimental Therapeutics, Vol. 346, Núm. 1, pp. 138-145

2012

  1. Involvement of carbonic anhydrases in the ocular hypotensive effect of melatonin analogue 5-MCA-NAT

    Journal of Pineal Research, Vol. 52, Núm. 3, pp. 265-270

  2. Ocular disorders and the utility of animal models in the discovery of melatoninergic drugs with therapeutic potential

    Expert Opinion on Drug Discovery, Vol. 7, Núm. 10, pp. 989-1001

2011

  1. Regulation of ocular adrenoceptor genes expression by 5-MCA-NAT: Implications for glaucoma treatment

    Pharmacogenetics and Genomics, Vol. 21, Núm. 9, pp. 587-589